Chronic Stress, Glucocorticoids, and Progesterone in Brain Aging

Information

  • Research Project
  • 10119641
  • ApplicationId
    10119641
  • Core Project Number
    R01AG037868
  • Full Project Number
    2R01AG037868-06A1
  • Serial Number
    037868
  • FOA Number
    PA-19-056
  • Sub Project Id
  • Project Start Date
    3/1/2011 - 14 years ago
  • Project End Date
    5/31/2026 - 5 months from now
  • Program Officer Name
    WISE, BRADLEY C
  • Budget Start Date
    9/15/2021 - 4 years ago
  • Budget End Date
    5/31/2022 - 3 years ago
  • Fiscal Year
    2021
  • Support Year
    06
  • Suffix
    A1
  • Award Notice Date
    9/14/2021 - 4 years ago

Chronic Stress, Glucocorticoids, and Progesterone in Brain Aging

Evidence indicates that prolonged/ repeated behavioral stress promotes brain aging. This is thought to be due, at least in part, to stress associated glucocorticoid (GC) secretion, which in turn binds to glucocorticoid receptors, exerting transcriptional and other effects. A key downstream mediator in this signaling pathway, serum-and- glucocorticoid kinase 1 (Sgk1) accelerates, and the female sex steroid progesterone (P4) blunts, the effects of GCs. However, despite the negative clinical consequences of chronic stress exposure with aging and/or in female subjects, little work has examined how aging may change the stress response, the mechanisms through which stress may accelerate brain aging, the degree to which stress-accelerated aging is dependent on GC, is driven by Sgk1, or is inhibited by P4. Our preliminary data suggests that hippocampal Sgk1 is upregulated by aging, stress, and GCs in white matter oligodendrocytes, and that the female sex hormone progesterone (P4) blunts the effects of stress/GCs and may serve as an endogenous protectant that is lost with age in females. To address these knowledge gaps, we propose 3 aims to investigate: the age-course of the response to chronic stress or chronic GCs in males and females; whether viral overexpression of Sgk1 exacerbates, or systemic P4 administration ameliorates, stress-accelerated aging; and whether the pharmacologic sensitivity of hippocampal tissue to GC and P4 is shifted with age or chronic stress/GC. Cognitive and anxiety-related behavior, blood hormone measures, and a novel panel of 205 hippocampal genes that are robustly changed with aging across multiple studies, will be used to test for stress/GC-accelerated aging and intervention effects, as will downstream gray and white matter Sgk1 expression and microglial response to microinjury- two processes demonstrated to be glucocorticoid sensitive and exaggerated in white vs. gray matter in preliminary data. Thus, the proposed studies will yield essentially the first comprehensive test of the hypothesis that chronic stress accelerates transcriptional brain aging and will illuminate sex differences in stress responsiveness and the potential roles of GC, P4, and Sgk1 in gray and white matter. Even if all of our working hypotheses are rejected by the results, the proposed studies should have translational value for geriatric medicine.

IC Name
NATIONAL INSTITUTE ON AGING
  • Activity
    R01
  • Administering IC
    AG
  • Application Type
    2
  • Direct Cost Amount
    258634
  • Indirect Cost Amount
    135772
  • Total Cost
    394406
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    866
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NIA:394406\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    NNRS
  • Study Section Name
    Neuroendocrinology, Neuroimmunology, Rhythms and Sleep Study Section
  • Organization Name
    UNIVERSITY OF KENTUCKY
  • Organization Department
    PHARMACOLOGY
  • Organization DUNS
    939017877
  • Organization City
    LEXINGTON
  • Organization State
    KY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    405260001
  • Organization District
    UNITED STATES